86
Participants
Start Date
October 7, 2021
Primary Completion Date
June 15, 2023
Study Completion Date
October 30, 2025
Elranatamab
BCMA-CD3 bispecific antibody
National Taiwan University Hospital, Taipei
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
Memorial Sloan Kettering Cancer Center, New York
MSK Westchester, Harrison
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
Taipei Veterans General Hospital, Taipei
MSK Nassau, Uniondale
MSK Commack, Commack
Fox Chase Cancer Center, Philadelphia
UF Health Shands Cancer Hospital, Gainesville
UF Health Shands Hospital Pharmacy Investigational Drug Service - Main, Gainesville
UF Health Shands Hospital, Gainesville
University of Florida, Gainesville
China Medical University Hospital, Taichung
Cleveland Clinic Taussig Cancer Institute, Cleveland
The Regents of the University of Michigan, Ann Arbor
University of Michigan, Ann Arbor
Henry Ford Hospital, Detroit
East Jefferson General Hospital Bone Marrow Transplant Clinic, Metairie
East Jefferson General Hospital, Metairie
Tulane University, New Orleans
Blood Cancer and Stem Cell Transplant Clinic, San Antonio
Methodist Healthcare System of San Antonio dba Methodist Hospital, San Antonio
Methodist Hospital Investigational Pharmacy, San Antonio
Methodist Plaza Clinical Trials Office, San Antonio
St. David's South Austin Medical Center, Austin
Texas Oncology - South Austin, Austin
Poudre Valley Hospital, Fort Collins
Cancer Care & Hematology - Fort Collins, Fort Collins
Poudre Valley Health System (PVHS), Fort Collins
UCHealth Cancer Care & Hematology - Loveland, Loveland
UCHealth Cancer Care & Hematology - Greeley, Greeley
Huntsman Cancer Institute, University of Utah, Salt Lake City
University of Utah, Salt Lake City
Mayo Clinic Hospital, Phoenix
Mayo Clinic, Scottsdale
MSK Basking Ridge, Basking Ridge
MSK Monmouth, Middletown
MSK Bergen, Montvale
Nagoya City University Hospital, Nagoya
Kobe City Medical Center General Hospital, Kobe
National Cancer Center Hospital, Chuo-ku
Japanese Red Cross Medical Center, Shibuya-ku
University Hospital,Kyoto Prefectural University of Medicine, Kyoto
University Hospitals Birmingham NHS Foundation Trust, Birmingham
University College London Hospitals NHS Foundation Trust, London
Guy's and St Thomas' NHS Foundation Trust, London
King's College Hospital NHS Foundation Trust, London
The Royal Marsden NHS Foundation Trust, London
University College London Hospitals NHS Foundation Trust NIHR, London
The Royal Marsden NHS Foundation Trust, Surrey
Lead Sponsor
Pfizer
INDUSTRY